tradingkey.logo

Caris Life Sciences Inc

CAI
Ver gráfico detallado

33.660USD

+0.540+1.63%
Cierre 09/16, 16:00ETCotizaciones retrasadas 15 min
9.46BCap. mercado
PérdidaP/E TTM

Caris Life Sciences Inc

33.660

+0.540+1.63%
Intraday
1m
30m
1h
D
W
M
D

Hoy

+1.63%

5 Días

-0.85%

1 Mes

-7.78%

6 Meses

0.00%

Año hasta la fecha

0.00%

Un año

0.00%

Ver gráfico detallado

Puntuación de acciones TradingKey

Sin datos de puntuación

Noticias

Próximamente más noticias, permanezca atento...

Indicadores financieros

BPA

Sin datos

Ingresos totales

Sin datos

Compañía

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
Símbolo de cotizaciónCAI
CompañíaCaris Life Sciences Inc
Director ejecutivoMr. David Dean Halbert
Sitio Webhttps://www.carislifesciences.com/
KeyAI